Related Experiment Videos
Pharmacokinetic interactions of ceftazidime and frusemide
G Chrysos1, P Gargalianos, M Lelekis
1General Hospital of Athens, Greece.
Journal of Chemotherapy (Florence, Italy)
|November 1, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Ceftazidime/avibactam in the era of carbapenemase-producing Klebsiella pneumoniae: experience from a national registry study.
The Journal of antimicrobial chemotherapy·2020
First-year results of an antibiotic stewardship program in a Greek tertiary care hospital.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2017
Prevalence of drug resistance among HIV-1 treatment-naive patients in Greece during 2003-2015: Transmitted drug resistance is due to onward transmissions.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases·2017
Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2015
Effects of highly active antiretroviral therapy on platelet activating factor metabolism in naive HIV-infected patients: ii) study of the abacavir/lamivudine/efavirenz HAART regimen.
International journal of immunopathology and pharmacology·2012
Impaired phagocytosis among patients infected by the human immunodeficiency virus: implication for a role of highly active anti-retroviral therapy.
Clinical and experimental immunology·2012
The emerging trends in prostate cancer treatment: a systematic review of the literature.
Journal of chemotherapy (Florence, Italy)·2026
Six-month progression-free survival-related tumor growth rate after upfront chemotherapy as an outcome measure and potential prognostic or stratification variable for patients with unresectable pancreatic adenocarcinoma: an exploratory study cohorts analysis.
Journal of chemotherapy (Florence, Italy)·2026
Pharmacogenomic biomarkers in oncology: evidence, clinical utility, and barriers to implementation.
Journal of chemotherapy (Florence, Italy)·2026
Efficacy and safety of TROP2 antibody-drug conjugate-containing regimen in the patients with HER2 negative metastatic breast cancer and advanced non-small-cell lung cancer.
Journal of chemotherapy (Florence, Italy)·2026
Efficacy and safety of PD-1/PD-L1 inhibitor-combined chemotherapy versus chemotherapy alone in extensive-stage small-cell lung cancer: a meta-analysis.
Journal of chemotherapy (Florence, Italy)·2026
Evaluating seltorexant as a treatment option for major depressive disorder.
Expert review of neurotherapeutics·2026
Effects of subcutaneous semaglutide on weight loss and inflammatory markers in adults with overweight or obesity without diabetes: a systematic review and meta-analysis.
International journal of obesity (2005)·2026